Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
15,024
archived clinical trials in
Infectious Disease

Tacrolimus and Mycophenolate Mofetil in Preventing Graft-Versus-Host Disease in Patients Who Have Undergone Total-Body Irradiation With or Without Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant for Hematologic Cancer
A Multi-Center Study of Nonmyeloablative Conditioning With TBI or Fludarabine/TBI for HLA-matched Related Hematopoietic Cell Transplantation for Treatment of Hematologic Malignancies With Post Grafting Immunosuppression With Tacrolimus and Mycophenolate Mofetil
Status: Enrolling
Updated:  12/31/1969
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
mi
from
Seattle, WA
Tacrolimus and Mycophenolate Mofetil in Preventing Graft-Versus-Host Disease in Patients Who Have Undergone Total-Body Irradiation With or Without Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant for Hematologic Cancer
A Multi-Center Study of Nonmyeloablative Conditioning With TBI or Fludarabine/TBI for HLA-matched Related Hematopoietic Cell Transplantation for Treatment of Hematologic Malignancies With Post Grafting Immunosuppression With Tacrolimus and Mycophenolate Mofetil
Status: Enrolling
Updated: 12/31/1969
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
mi
from
Seattle, WA
Click here to add this to my saved trials
Tacrolimus and Mycophenolate Mofetil in Preventing Graft-Versus-Host Disease in Patients Who Have Undergone Total-Body Irradiation With or Without Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant for Hematologic Cancer
A Multi-Center Study of Nonmyeloablative Conditioning With TBI or Fludarabine/TBI for HLA-matched Related Hematopoietic Cell Transplantation for Treatment of Hematologic Malignancies With Post Grafting Immunosuppression With Tacrolimus and Mycophenolate Mofetil
Status: Enrolling
Updated:  12/31/1969
VA Puget Sound Health Care System
mi
from
Seattle, WA
Tacrolimus and Mycophenolate Mofetil in Preventing Graft-Versus-Host Disease in Patients Who Have Undergone Total-Body Irradiation With or Without Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant for Hematologic Cancer
A Multi-Center Study of Nonmyeloablative Conditioning With TBI or Fludarabine/TBI for HLA-matched Related Hematopoietic Cell Transplantation for Treatment of Hematologic Malignancies With Post Grafting Immunosuppression With Tacrolimus and Mycophenolate Mofetil
Status: Enrolling
Updated: 12/31/1969
VA Puget Sound Health Care System
mi
from
Seattle, WA
Click here to add this to my saved trials
Tacrolimus and Mycophenolate Mofetil in Preventing Graft-Versus-Host Disease in Patients Who Have Undergone Total-Body Irradiation With or Without Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant for Hematologic Cancer
A Multi-Center Study of Nonmyeloablative Conditioning With TBI or Fludarabine/TBI for HLA-matched Related Hematopoietic Cell Transplantation for Treatment of Hematologic Malignancies With Post Grafting Immunosuppression With Tacrolimus and Mycophenolate Mofetil
Status: Enrolling
Updated:  12/31/1969
University of Torino
mi
from
Torino,
Tacrolimus and Mycophenolate Mofetil in Preventing Graft-Versus-Host Disease in Patients Who Have Undergone Total-Body Irradiation With or Without Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant for Hematologic Cancer
A Multi-Center Study of Nonmyeloablative Conditioning With TBI or Fludarabine/TBI for HLA-matched Related Hematopoietic Cell Transplantation for Treatment of Hematologic Malignancies With Post Grafting Immunosuppression With Tacrolimus and Mycophenolate Mofetil
Status: Enrolling
Updated: 12/31/1969
University of Torino
mi
from
Torino,
Click here to add this to my saved trials
Analysis of Lyme Disease Lesions
Analysis of Erythema Migrans Lesions
Status: Enrolling
Updated:  12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Analysis of Lyme Disease Lesions
Analysis of Erythema Migrans Lesions
Status: Enrolling
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Impact of Gender on Patients
Impact of Gender on Infected Hospitalized Patients
Status: Enrolling
Updated:  12/31/1969
Vanderbilt University
mi
from
Nashville, TN
Impact of Gender on Patients
Impact of Gender on Infected Hospitalized Patients
Status: Enrolling
Updated: 12/31/1969
Vanderbilt University
mi
from
Nashville, TN
Click here to add this to my saved trials
Impact of Gender on Patients
Impact of Gender on Infected Hospitalized Patients
Status: Enrolling
Updated:  12/31/1969
University of Virginia
mi
from
Charlottesville, VA
Impact of Gender on Patients
Impact of Gender on Infected Hospitalized Patients
Status: Enrolling
Updated: 12/31/1969
University of Virginia
mi
from
Charlottesville, VA
Click here to add this to my saved trials
NCCLS Interpretive Criteria for Salmonella
NCCLS Interpretive Criteria for Salmonella
Status: Enrolling
Updated:  12/31/1969
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
NCCLS Interpretive Criteria for Salmonella
NCCLS Interpretive Criteria for Salmonella
Status: Enrolling
Updated: 12/31/1969
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Piperacillin as a Part of Antibiotic Streamlining in the Intensive Care Unit
Piperacillin as a Part of Antibiotic Streamlining in the Intensive Care Unit
Status: Enrolling
Updated:  12/31/1969
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Piperacillin as a Part of Antibiotic Streamlining in the Intensive Care Unit
Piperacillin as a Part of Antibiotic Streamlining in the Intensive Care Unit
Status: Enrolling
Updated: 12/31/1969
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Nelfinavir and M8 Drug-level Monitoring in HIV-1 Infection
Nelfinavir and M8 Drug-level Monitoring in HIV-1 Infection
Status: Enrolling
Updated:  12/31/1969
University of Wisconsin Hospital and Clinics
mi
from
Madison, WI
Nelfinavir and M8 Drug-level Monitoring in HIV-1 Infection
Nelfinavir and M8 Drug-level Monitoring in HIV-1 Infection
Status: Enrolling
Updated: 12/31/1969
University of Wisconsin Hospital and Clinics
mi
from
Madison, WI
Click here to add this to my saved trials
RSV Disease in the Elderly
Pathogenesis of RSV Disease in the Elderly
Status: Enrolling
Updated:  12/31/1969
Rochester General Hospital
mi
from
Rochester, NY
RSV Disease in the Elderly
Pathogenesis of RSV Disease in the Elderly
Status: Enrolling
Updated: 12/31/1969
Rochester General Hospital
mi
from
Rochester, NY
Click here to add this to my saved trials
Stem Cell Transplantation in Idiopathic Inflammatory Myopathy Diseases
High Dose Cyclophosphamide & ATG With Hematopoietic Stem Cell Transplantation in Patients With Refractory Idiopathic Inflammatory Myopathy Diseases: A Phase I Trial
Status: Enrolling
Updated:  12/31/1969
Northwestern University Feinberg School of Medicine
mi
from
Chicago, IL
Stem Cell Transplantation in Idiopathic Inflammatory Myopathy Diseases
High Dose Cyclophosphamide & ATG With Hematopoietic Stem Cell Transplantation in Patients With Refractory Idiopathic Inflammatory Myopathy Diseases: A Phase I Trial
Status: Enrolling
Updated: 12/31/1969
Northwestern University Feinberg School of Medicine
mi
from
Chicago, IL
Click here to add this to my saved trials
Immune Reconstitution Syndrome in HIV-Infected Patients Taking Antiretroviral Therapy
A Cohort Observational Study Evaluating Predictors, Incidence and Immunopathogenesis of Immune Reconstitution Syndrome (IRIS) in HIV-1 Infected Patients With CD4 Count Less Than or Equal to 100 Cells/microL Who Are Initiating Antiretroviral Therapy
Status: Enrolling
Updated:  12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Immune Reconstitution Syndrome in HIV-Infected Patients Taking Antiretroviral Therapy
A Cohort Observational Study Evaluating Predictors, Incidence and Immunopathogenesis of Immune Reconstitution Syndrome (IRIS) in HIV-1 Infected Patients With CD4 Count Less Than or Equal to 100 Cells/microL Who Are Initiating Antiretroviral Therapy
Status: Enrolling
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Immune Reconstitution Syndrome in HIV-Infected Patients Taking Antiretroviral Therapy
A Cohort Observational Study Evaluating Predictors, Incidence and Immunopathogenesis of Immune Reconstitution Syndrome (IRIS) in HIV-1 Infected Patients With CD4 Count Less Than or Equal to 100 Cells/microL Who Are Initiating Antiretroviral Therapy
Status: Enrolling
Updated:  12/31/1969
The Thai Red Cross AID Research Center (TRC-ARC)
mi
from
Bangkok,
Immune Reconstitution Syndrome in HIV-Infected Patients Taking Antiretroviral Therapy
A Cohort Observational Study Evaluating Predictors, Incidence and Immunopathogenesis of Immune Reconstitution Syndrome (IRIS) in HIV-1 Infected Patients With CD4 Count Less Than or Equal to 100 Cells/microL Who Are Initiating Antiretroviral Therapy
Status: Enrolling
Updated: 12/31/1969
The Thai Red Cross AID Research Center (TRC-ARC)
mi
from
Bangkok,
Click here to add this to my saved trials
A Retrospective Review of Infections Usually Observed in Transplant Recipients
A Retrospective Review of Infections Usually Observed in Transplant Recipients
Status: Enrolling
Updated:  12/31/1969
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
A Retrospective Review of Infections Usually Observed in Transplant Recipients
A Retrospective Review of Infections Usually Observed in Transplant Recipients
Status: Enrolling
Updated: 12/31/1969
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
A Retrospective Review of Infections Usually Observed in Transplant Recipients
A Retrospective Review of Infections Usually Observed in Transplant Recipients
Status: Enrolling
Updated:  12/31/1969
UPMC
mi
from
Pittsburgh, PA
A Retrospective Review of Infections Usually Observed in Transplant Recipients
A Retrospective Review of Infections Usually Observed in Transplant Recipients
Status: Enrolling
Updated: 12/31/1969
UPMC
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Wound Infection Alexis Wound Retractor
Rate of Surgical Wound Infection After Open Appendectomy Using the Alexis Wound Retractor
Status: Enrolling
Updated:  12/31/1969
Santa Barbara Cottage Hospital
mi
from
Santa Barbara, CA
Wound Infection Alexis Wound Retractor
Rate of Surgical Wound Infection After Open Appendectomy Using the Alexis Wound Retractor
Status: Enrolling
Updated: 12/31/1969
Santa Barbara Cottage Hospital
mi
from
Santa Barbara, CA
Click here to add this to my saved trials
Immune Responses to Smallpox Vaccination
Immune Responses to Vaccinia Virus Vaccination
Status: Enrolling
Updated:  12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Immune Responses to Smallpox Vaccination
Immune Responses to Vaccinia Virus Vaccination
Status: Enrolling
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Continuation of Follow-up of DES-Exposed Cohorts
Continuation of Follow-up of DES-Exposed Cohorts
Status: Enrolling
Updated:  12/31/1969
Boston University School of Public Health
mi
from
Boston, MA
Continuation of Follow-up of DES-Exposed Cohorts
Continuation of Follow-up of DES-Exposed Cohorts
Status: Enrolling
Updated: 12/31/1969
Boston University School of Public Health
mi
from
Boston, MA
Click here to add this to my saved trials
Hyperglycemia in Surgical Infections
Studies on Hyperglycemia in Surgical Infections
Status: Enrolling
Updated:  12/31/1969
LBJ General Hospital/ UT health Science Center-Houston
mi
from
Houston, TX
Hyperglycemia in Surgical Infections
Studies on Hyperglycemia in Surgical Infections
Status: Enrolling
Updated: 12/31/1969
LBJ General Hospital/ UT health Science Center-Houston
mi
from
Houston, TX
Click here to add this to my saved trials
Hyperglycemia in Surgical Infections
Studies on Hyperglycemia in Surgical Infections
Status: Enrolling
Updated:  12/31/1969
Brooke Army Medical Center
mi
from
San Antonio, TX
Hyperglycemia in Surgical Infections
Studies on Hyperglycemia in Surgical Infections
Status: Enrolling
Updated: 12/31/1969
Brooke Army Medical Center
mi
from
San Antonio, TX
Click here to add this to my saved trials
Changing Patterns of Candida Infections in Urban Medical Centers
Changing Patterns of Candida Infections in Urban Medical Centers: Emphasis on the Emergence of Non-albicans Species and Their Influence on Clinical Outcomes
Status: Enrolling
Updated:  12/31/1969
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Changing Patterns of Candida Infections in Urban Medical Centers
Changing Patterns of Candida Infections in Urban Medical Centers: Emphasis on the Emergence of Non-albicans Species and Their Influence on Clinical Outcomes
Status: Enrolling
Updated: 12/31/1969
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Genetic Disorders of Mucociliary Clearance in Nontuberculous Mycobacterial Lung Disease
Genetic Disorders of Mucociliary Clearance
Status: Enrolling
Updated:  12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Genetic Disorders of Mucociliary Clearance in Nontuberculous Mycobacterial Lung Disease
Genetic Disorders of Mucociliary Clearance
Status: Enrolling
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Gemcitabine and Pemetrexed Disodium in Treating Patients With Advanced Mycosis Fungoides or Sézary Syndrome
Phase I/II Trial of Gemcitabine/Pemetrexed Combination in Patients With Advanced Cutaneous T-Cell Lymphoma
Status: Enrolling
Updated:  12/31/1969
Robert H. Lurie Comprehensive Cancer Center at Northwestern University
mi
from
Chicago, IL
Gemcitabine and Pemetrexed Disodium in Treating Patients With Advanced Mycosis Fungoides or Sézary Syndrome
Phase I/II Trial of Gemcitabine/Pemetrexed Combination in Patients With Advanced Cutaneous T-Cell Lymphoma
Status: Enrolling
Updated: 12/31/1969
Robert H. Lurie Comprehensive Cancer Center at Northwestern University
mi
from
Chicago, IL
Click here to add this to my saved trials
NMRC-M3V-Ad-PfCA Vaccine - Clinical Trial 1
A Two Part Clinical Trial Assessing the Safety, Tolerability, Immunogenicity and Protective Efficacy of NMRC-M3V-Ad-PfCA, a Multivalent, Adenovirus-Vectored Plasmodium Falciparum Malaria Vaccine, in Healthy, Malaria-Naïve Adults
Status: Enrolling
Updated:  12/31/1969
Naval Medical Research Center (NMRC) Clinical Trials Center
mi
from
Bethesda, MD
NMRC-M3V-Ad-PfCA Vaccine - Clinical Trial 1
A Two Part Clinical Trial Assessing the Safety, Tolerability, Immunogenicity and Protective Efficacy of NMRC-M3V-Ad-PfCA, a Multivalent, Adenovirus-Vectored Plasmodium Falciparum Malaria Vaccine, in Healthy, Malaria-Naïve Adults
Status: Enrolling
Updated: 12/31/1969
Naval Medical Research Center (NMRC) Clinical Trials Center
mi
from
Bethesda, MD
Click here to add this to my saved trials
Sirolimus for Autoimmune Disease of Blood Cells
Sirolimus for Patients With Chronic and/or Refractory Autoimmune Cytopenias: A Pilot Series
Status: Enrolling
Updated:  12/31/1969
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Sirolimus for Autoimmune Disease of Blood Cells
Sirolimus for Patients With Chronic and/or Refractory Autoimmune Cytopenias: A Pilot Series
Status: Enrolling
Updated: 12/31/1969
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Development of Serologic Assays for Human Herpes Virus-8
Development of Serologic Assays for Human Herpes Virus-8
Status: Enrolling
Updated:  12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Development of Serologic Assays for Human Herpes Virus-8
Development of Serologic Assays for Human Herpes Virus-8
Status: Enrolling
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
N-acetylcysteine in Intra-amniotic Infection/Inflammation
Effect of N-acetylcysteine in Preventing Adverse Neonatal Outcomes in Women With Intra-amniotic Infection/Inflammation
Status: Enrolling
Updated:  12/31/1969
Yale-New Haven Hospital
mi
from
New Haven, CT
N-acetylcysteine in Intra-amniotic Infection/Inflammation
Effect of N-acetylcysteine in Preventing Adverse Neonatal Outcomes in Women With Intra-amniotic Infection/Inflammation
Status: Enrolling
Updated: 12/31/1969
Yale-New Haven Hospital
mi
from
New Haven, CT
Click here to add this to my saved trials
N-acetylcysteine in Intra-amniotic Infection/Inflammation
Effect of N-acetylcysteine in Preventing Adverse Neonatal Outcomes in Women With Intra-amniotic Infection/Inflammation
Status: Enrolling
Updated:  12/31/1969
The Research Institute at Nationwide Children's Hospital
mi
from
Columbus, OH
N-acetylcysteine in Intra-amniotic Infection/Inflammation
Effect of N-acetylcysteine in Preventing Adverse Neonatal Outcomes in Women With Intra-amniotic Infection/Inflammation
Status: Enrolling
Updated: 12/31/1969
The Research Institute at Nationwide Children's Hospital
mi
from
Columbus, OH
Click here to add this to my saved trials
Recombinant Measles Virus Vaccine Therapy and Oncolytic Virus Therapy in Treating Patients With Progressive, Recurrent, or Refractory Ovarian Epithelial Cancer or Primary Peritoneal Cancer
Phase I Trial of Intraperitoneal Administration of a) a CEA-Expressing Derivative, and b) a NIS-Expressing Derivative Manufactured From a Genetically Engineered Strain of Measles Virus in Patients With Recurrent Ovarian Cancer
Status: Enrolling
Updated:  12/31/1969
The Mayo Clinic
mi
from
Rochester, MN
Recombinant Measles Virus Vaccine Therapy and Oncolytic Virus Therapy in Treating Patients With Progressive, Recurrent, or Refractory Ovarian Epithelial Cancer or Primary Peritoneal Cancer
Phase I Trial of Intraperitoneal Administration of a) a CEA-Expressing Derivative, and b) a NIS-Expressing Derivative Manufactured From a Genetically Engineered Strain of Measles Virus in Patients With Recurrent Ovarian Cancer
Status: Enrolling
Updated: 12/31/1969
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
Isavuconazole (BAL8557) for Primary Treatment of Invasive Aspergillosis
A Phase III, Double Blind, Randomized Study to Evaluate Safety and Efficacy of BAL8557 Versus Voriconazole for Primary Treatment of Invasive Fungal Disease Caused by Aspergillus Species or Other Filamentous Fungi.
Status: Enrolling
Updated:  12/31/1969
University of California at San Francisco
mi
from
San Francisco, CA
Isavuconazole (BAL8557) for Primary Treatment of Invasive Aspergillosis
A Phase III, Double Blind, Randomized Study to Evaluate Safety and Efficacy of BAL8557 Versus Voriconazole for Primary Treatment of Invasive Fungal Disease Caused by Aspergillus Species or Other Filamentous Fungi.
Status: Enrolling
Updated: 12/31/1969
University of California at San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
Isavuconazole (BAL8557) for Primary Treatment of Invasive Aspergillosis
A Phase III, Double Blind, Randomized Study to Evaluate Safety and Efficacy of BAL8557 Versus Voriconazole for Primary Treatment of Invasive Fungal Disease Caused by Aspergillus Species or Other Filamentous Fungi.
Status: Enrolling
Updated:  12/31/1969
University of Chicago, Division of Infectious Diseases
mi
from
Chicago, IL
Isavuconazole (BAL8557) for Primary Treatment of Invasive Aspergillosis
A Phase III, Double Blind, Randomized Study to Evaluate Safety and Efficacy of BAL8557 Versus Voriconazole for Primary Treatment of Invasive Fungal Disease Caused by Aspergillus Species or Other Filamentous Fungi.
Status: Enrolling
Updated: 12/31/1969
University of Chicago, Division of Infectious Diseases
mi
from
Chicago, IL
Click here to add this to my saved trials
Isavuconazole (BAL8557) for Primary Treatment of Invasive Aspergillosis
A Phase III, Double Blind, Randomized Study to Evaluate Safety and Efficacy of BAL8557 Versus Voriconazole for Primary Treatment of Invasive Fungal Disease Caused by Aspergillus Species or Other Filamentous Fungi.
Status: Enrolling
Updated:  12/31/1969
Indiana BMT
mi
from
Springfield, IL
Isavuconazole (BAL8557) for Primary Treatment of Invasive Aspergillosis
A Phase III, Double Blind, Randomized Study to Evaluate Safety and Efficacy of BAL8557 Versus Voriconazole for Primary Treatment of Invasive Fungal Disease Caused by Aspergillus Species or Other Filamentous Fungi.
Status: Enrolling
Updated: 12/31/1969
Indiana BMT
mi
from
Springfield, IL
Click here to add this to my saved trials
Isavuconazole (BAL8557) for Primary Treatment of Invasive Aspergillosis
A Phase III, Double Blind, Randomized Study to Evaluate Safety and Efficacy of BAL8557 Versus Voriconazole for Primary Treatment of Invasive Fungal Disease Caused by Aspergillus Species or Other Filamentous Fungi.
Status: Enrolling
Updated:  12/31/1969
Infectious Disease of Indiana
mi
from
Indianapolis, IN
Isavuconazole (BAL8557) for Primary Treatment of Invasive Aspergillosis
A Phase III, Double Blind, Randomized Study to Evaluate Safety and Efficacy of BAL8557 Versus Voriconazole for Primary Treatment of Invasive Fungal Disease Caused by Aspergillus Species or Other Filamentous Fungi.
Status: Enrolling
Updated: 12/31/1969
Infectious Disease of Indiana
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Isavuconazole (BAL8557) for Primary Treatment of Invasive Aspergillosis
A Phase III, Double Blind, Randomized Study to Evaluate Safety and Efficacy of BAL8557 Versus Voriconazole for Primary Treatment of Invasive Fungal Disease Caused by Aspergillus Species or Other Filamentous Fungi.
Status: Enrolling
Updated:  12/31/1969
Brigham and Women's Hosp
mi
from
Boston, MA
Isavuconazole (BAL8557) for Primary Treatment of Invasive Aspergillosis
A Phase III, Double Blind, Randomized Study to Evaluate Safety and Efficacy of BAL8557 Versus Voriconazole for Primary Treatment of Invasive Fungal Disease Caused by Aspergillus Species or Other Filamentous Fungi.
Status: Enrolling
Updated: 12/31/1969
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
Isavuconazole (BAL8557) for Primary Treatment of Invasive Aspergillosis
A Phase III, Double Blind, Randomized Study to Evaluate Safety and Efficacy of BAL8557 Versus Voriconazole for Primary Treatment of Invasive Fungal Disease Caused by Aspergillus Species or Other Filamentous Fungi.
Status: Enrolling
Updated:  12/31/1969
Upstate Infectious Diseases Association LLP
mi
from
Albany, NY
Isavuconazole (BAL8557) for Primary Treatment of Invasive Aspergillosis
A Phase III, Double Blind, Randomized Study to Evaluate Safety and Efficacy of BAL8557 Versus Voriconazole for Primary Treatment of Invasive Fungal Disease Caused by Aspergillus Species or Other Filamentous Fungi.
Status: Enrolling
Updated: 12/31/1969
Upstate Infectious Diseases Association LLP
mi
from
Albany, NY
Click here to add this to my saved trials
Isavuconazole (BAL8557) for Primary Treatment of Invasive Aspergillosis
A Phase III, Double Blind, Randomized Study to Evaluate Safety and Efficacy of BAL8557 Versus Voriconazole for Primary Treatment of Invasive Fungal Disease Caused by Aspergillus Species or Other Filamentous Fungi.
Status: Enrolling
Updated:  12/31/1969
Regional Infection Diseases Infusion Center Inc.
mi
from
Lima, OH
Isavuconazole (BAL8557) for Primary Treatment of Invasive Aspergillosis
A Phase III, Double Blind, Randomized Study to Evaluate Safety and Efficacy of BAL8557 Versus Voriconazole for Primary Treatment of Invasive Fungal Disease Caused by Aspergillus Species or Other Filamentous Fungi.
Status: Enrolling
Updated: 12/31/1969
Regional Infection Diseases Infusion Center Inc.
mi
from
Lima, OH
Click here to add this to my saved trials
Isavuconazole (BAL8557) for Primary Treatment of Invasive Aspergillosis
A Phase III, Double Blind, Randomized Study to Evaluate Safety and Efficacy of BAL8557 Versus Voriconazole for Primary Treatment of Invasive Fungal Disease Caused by Aspergillus Species or Other Filamentous Fungi.
Status: Enrolling
Updated:  12/31/1969
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Isavuconazole (BAL8557) for Primary Treatment of Invasive Aspergillosis
A Phase III, Double Blind, Randomized Study to Evaluate Safety and Efficacy of BAL8557 Versus Voriconazole for Primary Treatment of Invasive Fungal Disease Caused by Aspergillus Species or Other Filamentous Fungi.
Status: Enrolling
Updated: 12/31/1969
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Isavuconazole (BAL8557) for Primary Treatment of Invasive Aspergillosis
A Phase III, Double Blind, Randomized Study to Evaluate Safety and Efficacy of BAL8557 Versus Voriconazole for Primary Treatment of Invasive Fungal Disease Caused by Aspergillus Species or Other Filamentous Fungi.
Status: Enrolling
Updated:  12/31/1969
University of Alabama
mi
from
Birmingham, AL
Isavuconazole (BAL8557) for Primary Treatment of Invasive Aspergillosis
A Phase III, Double Blind, Randomized Study to Evaluate Safety and Efficacy of BAL8557 Versus Voriconazole for Primary Treatment of Invasive Fungal Disease Caused by Aspergillus Species or Other Filamentous Fungi.
Status: Enrolling
Updated: 12/31/1969
University of Alabama
mi
from
Birmingham, AL
Click here to add this to my saved trials
Isavuconazole (BAL8557) for Primary Treatment of Invasive Aspergillosis
A Phase III, Double Blind, Randomized Study to Evaluate Safety and Efficacy of BAL8557 Versus Voriconazole for Primary Treatment of Invasive Fungal Disease Caused by Aspergillus Species or Other Filamentous Fungi.
Status: Enrolling
Updated:  12/31/1969
Springfield Clinic, LLP
mi
from
Springfield, IL
Isavuconazole (BAL8557) for Primary Treatment of Invasive Aspergillosis
A Phase III, Double Blind, Randomized Study to Evaluate Safety and Efficacy of BAL8557 Versus Voriconazole for Primary Treatment of Invasive Fungal Disease Caused by Aspergillus Species or Other Filamentous Fungi.
Status: Enrolling
Updated: 12/31/1969
Springfield Clinic, LLP
mi
from
Springfield, IL
Click here to add this to my saved trials
Isavuconazole (BAL8557) for Primary Treatment of Invasive Aspergillosis
A Phase III, Double Blind, Randomized Study to Evaluate Safety and Efficacy of BAL8557 Versus Voriconazole for Primary Treatment of Invasive Fungal Disease Caused by Aspergillus Species or Other Filamentous Fungi.
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Worcester, MA
Isavuconazole (BAL8557) for Primary Treatment of Invasive Aspergillosis
A Phase III, Double Blind, Randomized Study to Evaluate Safety and Efficacy of BAL8557 Versus Voriconazole for Primary Treatment of Invasive Fungal Disease Caused by Aspergillus Species or Other Filamentous Fungi.
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Worcester, MA
Click here to add this to my saved trials
Isavuconazole (BAL8557) for Primary Treatment of Invasive Aspergillosis
A Phase III, Double Blind, Randomized Study to Evaluate Safety and Efficacy of BAL8557 Versus Voriconazole for Primary Treatment of Invasive Fungal Disease Caused by Aspergillus Species or Other Filamentous Fungi.
Status: Enrolling
Updated:  12/31/1969
mi
from
Buenos Aires,
Isavuconazole (BAL8557) for Primary Treatment of Invasive Aspergillosis
A Phase III, Double Blind, Randomized Study to Evaluate Safety and Efficacy of BAL8557 Versus Voriconazole for Primary Treatment of Invasive Fungal Disease Caused by Aspergillus Species or Other Filamentous Fungi.
Status: Enrolling
Updated: 12/31/1969
mi
from
Buenos Aires,
Click here to add this to my saved trials
Isavuconazole (BAL8557) in the Treatment of Candidemia and Other Invasive Candida Infections
A Phase III, Double-blind, Randomized Study to Evaluate the Safety and Efficacy of BAL8557 Versus a Caspofungin Followed by Voriconazole Regimen in the Treatment of Candidemia and Other Invasive Candida Infections
Status: Enrolling
Updated:  12/31/1969
Henry Ford Hospital
mi
from
Detroit, MI
Isavuconazole (BAL8557) in the Treatment of Candidemia and Other Invasive Candida Infections
A Phase III, Double-blind, Randomized Study to Evaluate the Safety and Efficacy of BAL8557 Versus a Caspofungin Followed by Voriconazole Regimen in the Treatment of Candidemia and Other Invasive Candida Infections
Status: Enrolling
Updated: 12/31/1969
Henry Ford Hospital
mi
from
Detroit, MI
Click here to add this to my saved trials
Isavuconazole (BAL8557) in the Treatment of Candidemia and Other Invasive Candida Infections
A Phase III, Double-blind, Randomized Study to Evaluate the Safety and Efficacy of BAL8557 Versus a Caspofungin Followed by Voriconazole Regimen in the Treatment of Candidemia and Other Invasive Candida Infections
Status: Enrolling
Updated:  12/31/1969
Infectious Disease of Indiana
mi
from
Indianapolis, IN
Isavuconazole (BAL8557) in the Treatment of Candidemia and Other Invasive Candida Infections
A Phase III, Double-blind, Randomized Study to Evaluate the Safety and Efficacy of BAL8557 Versus a Caspofungin Followed by Voriconazole Regimen in the Treatment of Candidemia and Other Invasive Candida Infections
Status: Enrolling
Updated: 12/31/1969
Infectious Disease of Indiana
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Isavuconazole (BAL8557) in the Treatment of Candidemia and Other Invasive Candida Infections
A Phase III, Double-blind, Randomized Study to Evaluate the Safety and Efficacy of BAL8557 Versus a Caspofungin Followed by Voriconazole Regimen in the Treatment of Candidemia and Other Invasive Candida Infections
Status: Enrolling
Updated:  12/31/1969
Jersey Shore University Medical Center
mi
from
Neptune, NJ
Isavuconazole (BAL8557) in the Treatment of Candidemia and Other Invasive Candida Infections
A Phase III, Double-blind, Randomized Study to Evaluate the Safety and Efficacy of BAL8557 Versus a Caspofungin Followed by Voriconazole Regimen in the Treatment of Candidemia and Other Invasive Candida Infections
Status: Enrolling
Updated: 12/31/1969
Jersey Shore University Medical Center
mi
from
Neptune, NJ
Click here to add this to my saved trials
Isavuconazole (BAL8557) in the Treatment of Candidemia and Other Invasive Candida Infections
A Phase III, Double-blind, Randomized Study to Evaluate the Safety and Efficacy of BAL8557 Versus a Caspofungin Followed by Voriconazole Regimen in the Treatment of Candidemia and Other Invasive Candida Infections
Status: Enrolling
Updated:  12/31/1969
Loyola University Hospital
mi
from
Maywood, IL
Isavuconazole (BAL8557) in the Treatment of Candidemia and Other Invasive Candida Infections
A Phase III, Double-blind, Randomized Study to Evaluate the Safety and Efficacy of BAL8557 Versus a Caspofungin Followed by Voriconazole Regimen in the Treatment of Candidemia and Other Invasive Candida Infections
Status: Enrolling
Updated: 12/31/1969
Loyola University Hospital
mi
from
Maywood, IL
Click here to add this to my saved trials
Isavuconazole (BAL8557) in the Treatment of Candidemia and Other Invasive Candida Infections
A Phase III, Double-blind, Randomized Study to Evaluate the Safety and Efficacy of BAL8557 Versus a Caspofungin Followed by Voriconazole Regimen in the Treatment of Candidemia and Other Invasive Candida Infections
Status: Enrolling
Updated:  12/31/1969
Mercury Street Medical Group, Pllc
mi
from
Butte, MT
Isavuconazole (BAL8557) in the Treatment of Candidemia and Other Invasive Candida Infections
A Phase III, Double-blind, Randomized Study to Evaluate the Safety and Efficacy of BAL8557 Versus a Caspofungin Followed by Voriconazole Regimen in the Treatment of Candidemia and Other Invasive Candida Infections
Status: Enrolling
Updated: 12/31/1969
Mercury Street Medical Group, Pllc
mi
from
Butte, MT
Click here to add this to my saved trials
Isavuconazole (BAL8557) in the Treatment of Candidemia and Other Invasive Candida Infections
A Phase III, Double-blind, Randomized Study to Evaluate the Safety and Efficacy of BAL8557 Versus a Caspofungin Followed by Voriconazole Regimen in the Treatment of Candidemia and Other Invasive Candida Infections
Status: Enrolling
Updated:  12/31/1969
New York-Presbyterian Hospital
mi
from
New York, NY
Isavuconazole (BAL8557) in the Treatment of Candidemia and Other Invasive Candida Infections
A Phase III, Double-blind, Randomized Study to Evaluate the Safety and Efficacy of BAL8557 Versus a Caspofungin Followed by Voriconazole Regimen in the Treatment of Candidemia and Other Invasive Candida Infections
Status: Enrolling
Updated: 12/31/1969
New York-Presbyterian Hospital
mi
from
New York, NY
Click here to add this to my saved trials
Isavuconazole (BAL8557) in the Treatment of Candidemia and Other Invasive Candida Infections
A Phase III, Double-blind, Randomized Study to Evaluate the Safety and Efficacy of BAL8557 Versus a Caspofungin Followed by Voriconazole Regimen in the Treatment of Candidemia and Other Invasive Candida Infections
Status: Enrolling
Updated:  12/31/1969
Regional Infection Diseases Infusion Center Inc.
mi
from
Lima, OH
Isavuconazole (BAL8557) in the Treatment of Candidemia and Other Invasive Candida Infections
A Phase III, Double-blind, Randomized Study to Evaluate the Safety and Efficacy of BAL8557 Versus a Caspofungin Followed by Voriconazole Regimen in the Treatment of Candidemia and Other Invasive Candida Infections
Status: Enrolling
Updated: 12/31/1969
Regional Infection Diseases Infusion Center Inc.
mi
from
Lima, OH
Click here to add this to my saved trials
Isavuconazole (BAL8557) in the Treatment of Candidemia and Other Invasive Candida Infections
A Phase III, Double-blind, Randomized Study to Evaluate the Safety and Efficacy of BAL8557 Versus a Caspofungin Followed by Voriconazole Regimen in the Treatment of Candidemia and Other Invasive Candida Infections
Status: Enrolling
Updated:  12/31/1969
Temple University Health Sciences
mi
from
Philadelphia, PA
Isavuconazole (BAL8557) in the Treatment of Candidemia and Other Invasive Candida Infections
A Phase III, Double-blind, Randomized Study to Evaluate the Safety and Efficacy of BAL8557 Versus a Caspofungin Followed by Voriconazole Regimen in the Treatment of Candidemia and Other Invasive Candida Infections
Status: Enrolling
Updated: 12/31/1969
Temple University Health Sciences
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Isavuconazole (BAL8557) in the Treatment of Candidemia and Other Invasive Candida Infections
A Phase III, Double-blind, Randomized Study to Evaluate the Safety and Efficacy of BAL8557 Versus a Caspofungin Followed by Voriconazole Regimen in the Treatment of Candidemia and Other Invasive Candida Infections
Status: Enrolling
Updated:  12/31/1969
University of Alabama at Birmingham
mi
from
Birmingham, AL
Isavuconazole (BAL8557) in the Treatment of Candidemia and Other Invasive Candida Infections
A Phase III, Double-blind, Randomized Study to Evaluate the Safety and Efficacy of BAL8557 Versus a Caspofungin Followed by Voriconazole Regimen in the Treatment of Candidemia and Other Invasive Candida Infections
Status: Enrolling
Updated: 12/31/1969
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials